If you have less than a minute:
- the US are on track to meet their objective to offer vaccine eligibility to all adults by May 1st.
- More data shows AstraZeneca vaccine is effective, and Pfizer progresses in developing a new treatment drug for early-stage Covid.
Read more:
Research
- The AstraZeneca vaccine showed 76% efficacy against symptomatic coronavirus disease and 100% efficacy against severe or critical disease or the need for hospitalization.
- Pfizer trials has begun an early-stage clinical trial testing its experimental oral antiviral drug for Covid-19. This new pill could stop early-stage Covid in its tracks.
US
- More than 40 states say they will meet or beat Biden’s May 1 deadline for vaccine eligibility for all adults.
- Biden says his new goal is to reach 200 million vaccine shots in his first 100 days. “On Dec. 8, I indicated I hope to get 100 million shots in people’s arms in my first 100 days,” Biden said last Thursday. “We met that goal last week by Day 58, 42 days ahead of schedule. Today, I’m setting a second goal.”
- New York: After dropping for several weeks, the number of new COVID-19 cases in the city has stabilized, allowing the city to take more steps toward easing coronavirus restrictions.
UK
- Public Health England (PHE) analysis indicates that the COVID-19 vaccination program prevented 6,100 deaths in those aged 70 and older in England up to the end of February.
EU
- EU leaders are to hold virtual talks to discuss ways of boosting Covid vaccine supplies and improving the rollout of doses across the 27-nation bloc.
- The UK and the European Union have said they are working together to improve their relationship, after weeks of tensions over Covid vaccine supplies. In a joint statement, they said they wanted to "create a win-win situation and expand vaccine supply for all".
Asia Pacific
- Over 3,000 people in Taiwan received the AstraZeneca COVID-19 vaccine in the first two days of the vaccine roll-out.
